Chiesi Farmaceutici S.p.A

Chiesi Farmaceutici S.p.A is a pharmaceutical company based in Parma, Italy. It was founded in 1935 by Giacomo Chiesi, a pharmacist who started his own laboratory to produce medicines for local patients. Today, the company is still owned and managed by the Chiesi family and has grown to become one of the largest and most innovative pharmaceutical companies in Italy and Europe.

RChiesi Farmaceutici S.p.A specializes in the research, development, production, and marketing of medicines for respiratory, cardiovascular, neonatal, and rare diseases. The company has a strong presence in over 80 countries, with 29 affiliates and 6 production sites. On May 13th, 2023, the company reported a market cap of $8.4B.

Chiesi Farmaceutici S.p.A has a vision to improve the quality of life of patients and their families through innovative and sustainable solutions. The company invests heavily in research and development, with more than 20% of its revenue dedicated to R&D activities. The company also collaborates with academic institutions, biotech companies, and patient organizations to foster scientific excellence and social responsibility.

Chiesi Farmaceutici S.p.A has received several awards and recognitions for its achievements and contributions to the pharmaceutical industry and society. In 2020, the company was ranked among the top 10 best workplaces in Italy by Great Place to Work Institute. The company also received the European Responsible Care Award for its commitment to environmental sustainability and social impact.

Foundation: 1935
Headquarters: Parma, Italy
Website: https://www.chiesi.com/